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 INTRODUCTION 
 Malaria and human immunodeficiency virus (HIV) are 
among the most prevalent infectious diseases worldwide, with 
~2.7 million new HIV infections, two million acquired immu-
nodeficiency syndrome (AIDS)-related deaths, and nearly 
one million malaria deaths occurring globally in 2008. 1, 2 In the 
context of co-infection with both HIV and malaria, mount-
ing evidence suggests that interaction between the two occurs 
synergistically, with each disease contributing to substantial 
excess infections and dissemination of the other. 3 Co-infection 
is of special concern for pregnant women, of whom there 
are an estimated 25 million at risk for malaria infection each 
year in hyper-endemic regions of sub-Saharan Africa. 4, 5 The 
HIV-infected women may have reduced immunity to malaria 
infection and increased risk of placental malaria and clinical 
disease. 6, 7 Conversely, co-infection with malaria is associated 
with increased maternal HIV viral load 8 and adverse health 
outcomes. 3, 6, 9 
 Among HIV-1-infected pregnant women, severe and recur-
rent malaria infection with placental malaria (PM) may 
increase the risk of mother-to-child transmission (MTCT) of 
HIV, yet studies assessing the relationship between PM infec-
tion and MTCT of HIV-1 have reported varying results. 10– 15 A 
study conducted in rural Rakai District in Southern Uganda 
reported a significant association between PM and MTCT after 
controlling for HIV viral load. 14 In contrast, a study conducted 
in Mombasa, Kenya did not observe an association between 
PM and MTCT, 13 and data from the urban HIVNET 024 trial 
did not show this association overall, although an association 
was observed in a subset of women with low viral load at base-
line. 10 A study in rural Nyanza Province, Kenya reported an 
increased risk of MTCT of HIV-1 in women with high density 
PM compared with low density PM, but no overall increased 
risk of MTCT with PM. 15 Discrepancies in findings among 
these studies may be attributed to variations in study popula-
tion, prevalence of HIV or malaria, disease duration, seasonal 
timing, or host response in different settings. 14 We examined 
the relationship between PM and MTCT of HIV-1 among 
antiretroviral treatment-naive women and infants enrolled 
in a prospective cohort study in Butare, Rwanda from 1989 
to 1994. 
 METHODS 
 Study population and design.  This case-control study was 
nested within a prospective cohort study conducted between 
October 1989 and April 1994 of 318 HIV-1 seropositive and 
309 HIV-1 seronegative women enrolled during pregnancy at 
one of five collaborating health centers in Butare Province, a 
rural but densely-populated region of southern Rwanda with 
an altitude between 1450 and 1850 meters above sea level. 
All women were offered HIV-1 antibody testing during their 
first prenatal visit; HIV prevalence was 9.3% overall. 16 Cohort 
enrollment procedures have been described elsewhere. 17, 18 
Women were enrolled in the cohort at the second prenatal 
visit (median, 32 completed weeks of gestation) and encour-
aged to deliver at one of two maternity wards serving the 
region. Lymphocyte measurements were taken at the time of 
cohort enrollment. In case of home delivery, the placenta was 
collected by a study team member within 6 hours of birth and 
neonatal examinations were performed by a physician within 
48 hours of birth. Mother-infant follow-up was carried out at 
6-week intervals during the first year of life and at 4-month 
intervals thereafter until the child reached 3 years of age or 
when the study ended in April 1994. 18 The follow-up rate 
among mother-infant pairs in the study was 96% in the first 
year postpartum and the MTCT rate by 12 months of age was 
estimated at 25%. 19 Psychosocial support and individual coun-
seling regarding prevention of HIV-1 transmission were avail-
able to women and their partners on a weekly basis at study 
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clinics; however, antiretroviral treatment was not available 
at the time of the study. Approval for this study was granted 
by the Rwandan Ministry of Health and the Johns Hopkins 
University School of Hygiene and Public Health Institutional 
Review Board (IRB). An exempt approval was granted by 
the Stanford University human subjects’ protection panel for 
analysis of the data. 
 This study design is a case-control study nested within the 
original cohort, comparing 20 HIV-infected mother-infant 
pairs (perinatal transmitters), 20 HIV-infected mothers who 
did not transmit to their infant (non-transmitters), and 20 
HIV-uninfected mother-infant pairs. Non-transmitters were 
selected at random from all such women in the cohort with 
placenta specimens available. Infant HIV infection was deter-
mined by DNA polymerase chain reaction (PCR) performed 
on peripheral blood mononuclear cells collected at 4–6 weeks 
of age. 20 In surviving infants, antibody tests were performed at 
9, 12, 16, and 20 months of age to confirm HIV status. Twenty 
mother-infant pairs fulfilled the study inclusion criteria as 
“transmitters”: 1) an adequate placenta specimen was avail-
able for pathological examination, and 2) the infant was found 
positive by HIV DNA PCR at 4–6 weeks of age. Information 
on maternal CD4 count, CD4%, ultrasensitive p24 antigen 
level, delivery outcome, and sexual history were also available. 
Twenty non-transmitter pairs and 20 HIV-negative mother-
infant pairs were randomly selected among all other mother-
infant pairs in the study and compared with regard to PM and 
other clinical and demographic variables. 
 Histological examination.  At delivery, the placenta, fetal 
membranes (chorion and amnion), and an umbilical cord sam-
ple were collected for microscopic examination at the National 
University of Rwanda project laboratory. 17 Of 627 mother-
infant pairs enrolled in the cohort study, 543 (87%) placentas 
were collected and microscopically examined at the project 
laboratory. Each placenta was also weighed and any physical 
abnormality (such as infarction) was noted. Detailed PM evalu-
ations were conducted at the Johns Hopkins University School 
of Medicine within 3 years of placenta collection. A large sec-
tion of fetal placenta comprising an area of at least 2 cm 2 was 
examined histologically. In addition, a section of chorioamni-
otic roll consisting of at least 2 cm 2 of chorioamniotic tissue 
and a cross section of cord vessels were examined. Formalin-
fixed, paraffin-embedded placental tissues were sectioned for 
hematoxylin and eosin (H&E) staining. Giemsa staining and 
immunohistochemistry were performed on the placental disk 
with a primary monoclonal antibody (3A4) to  Plasmodium 
falciparum and a secondary peroxidase antibody. 21, 22 
 Focal villitis and infiltration of the intervillous space with 
macrophages containing birefringent hemazoin pigment and/
or the presence of malarial organisms were considered evi-
dence of active malarial infection 23 and were categorized as 
malaria positive. Malaria-negative placentas did not have any 
of the typical changes seen in active malarial infection, includ-
ing focal villitis, cellular infiltration of the intervillous space, 
chorioamnionitis, or vasculitis. Occasional placentas had only 
minimal hemazoin pigment without the presence of parasites. 
These were deemed indicative of past infection and were cat-
egorized as malaria negative. Immunohistochemical analysis 
was performed as a confirmatory diagnostic method (with 
no discordant results) using the avidin-biotin complex tech-
nique with peroxidase as the substrate for color reaction with 
3,3′-disminobenzidine tetrahydrochloride. Matched isotype 
controls at the same concentration were used. The pathologist 
reading the slides was blinded to all clinical data and labora-
tory test results. 
 Statistical analysis.  Chi-square (χ 2 ) tests or Fisher’s exact 
tests were used to test for overall association between HIV-1 
transmission and categorical covariates. Double-sided  P values 
≤ 0.05 were considered statistically significant. The Student’s 
 t test was used to test for differences in the mean of continuous 
variables according to HIV-1 transmission status. The associa-
tion between PM and MTCT of HIV-1 was evaluated using 
multivariate logistic regression modeling to estimate crude 
and adjusted odds ratios (OR and aOR) and 95% confidence 
intervals (CI). The final multivariate model included poten-
tial confounders such as CD4% and ultrasensitive p24 anti-
gen; other factors that were significantly associated with PM in 
univariate analyses were examined but excluded. CD4% was 
used as a marker of immunosuppression because absolute 
maternal CD4 counts have been shown to vary substantially 
during the antenatal through postpartum period, 24 whereas 
CD4% has been shown to remain stable from late pregnancy 
to 6 weeks postpartum. 25 All statistical analyses were con-
ducted using SAS version 9.1 (SAS Institute, Cary, NC). 
 RESULTS 
 Characteristics of the study population.  Characteristics 
of the study population according to HIV infection and 
mother-to-child transmission status (transmitter or non-
transmitter) are presented in  Table 1 . Compared with HIV-
positive women, HIV-negative women were generally older 
( P < 0.005), reported fewer years of education, and lower 
household income. Babies born to HIV-negative women were 
more likely ( P < 0.05) to weigh 2,500 grams or more at birth 
than babies of HIV-positive women. HIV-negative women 
were significantly less likely than HIV-positive women to 
report any sex partner other than the father of the baby dur-
ing pregnancy ( P < 0.005) or any history of a sexually transmit-
ted disease in the past three years ( P < 0.05). 
 Compared with non-transmitting women ( Table 1 ), trans-
mitters were somewhat more likely than non-transmitters to 
be primigravid, to report a sex partner other than the father 
of the baby during pregnancy, and to report laboratory-con-
firmed malaria in the past 3 years. Transmitters had signifi-
cantly lower average CD4+ cell counts than non-transmitters 
(357 versus 680, respectively). Maternal age, monthly house-
hold income, education, number of sexually transmitted dis-
eases in the past 3 years (self-reported), and number of AIDS 
symptoms were not significantly different between transmitter 
and non-transmitter mothers. 
 Placental malaria and MTCT of HIV-1.  Of the 60 placentas 
selected from the mother-infant pairs, 45% showed evidence 
of PM upon examination, with prevalence of PM differing sig-
nificantly between transmitting (75%) and non-transmitting 
(35%) HIV-positive women ( Table 2 ). Placental malaria was 
significantly associated with increased risk of MTCT of HIV-1 
univariately (OR = 5.6; 95% CI = 1.4–21.9). Placental mem-
brane roll inflammation (chorioamnionitis) was also associ-
ated with an increased risk of MTCT, although the association 
was not statistically significant (OR = 4.8; 95% CI = 0.9–27.2). 
Low maternal CD4/CD8 ratio (< 0.5), low CD4% (< 30%), 
and low placental weight (< 450 grams) also appeared to 
be associated with increased risk of MTCT (OR = 2.8; 95% 
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CI = 0.7–11.9, OR = 4.0; 95% CI = 1.0–16.3, OR = 2.4; 95% 
CI = 0.5–11.5, respectively). Primigravidae, birth weight, ultra-
sensitive p24 antigen, duration of membrane rupture, syphilis 
infection, and number of other sex partners during pregnancy 
were not significantly associated with MTCT in this analysis. 
Placental malaria was strongly associated with birth weight 
lower than 2,500 grams ( P = 0.02, χ 2 ) but not with other 
variables. 
 Table 3 shows the results of multivariate regression mod-
eling of MTCT by PM adjusting simultaneously for maternal 
CD4% and ultrasensitive p24 antigen. The PM was indepen-
dently associated with significantly increased risk of MTCT of 
HIV-1 after adjusting for maternal CD4% and ultrasensitive 
p24 antigen (aOR = 6.3; 95% CI = 1.4–29.1), with the strongest 
association seen among primigravidae (aOR = 12.0; 95% CI = 
1.0–150;  P < 0.05). Maternal CD4% below 30 was also mar-
ginally associated with increased risk of MTCT in this model 
(aOR = 4.8; 95% CI = 1.0–24.0). Ultrasensitive p24 antigen 
was not associated with MTCT of HIV-1 in univariate or mul-
tivariate analysis. Inclusion of other measured variables as 
potential confounders did not change the adjusted odds ratios 
appreciably. 
 Table 1 
 Characteristics of mothers at enrollment by HIV-1 mother-to-child 
transmission status, Butare, Rwanda, 1989–1994 * 
Characteristic
Transmitters 
 N (%)
Non-transmitters 
 N (%)
HIV-negative 
 N (%)
Total † 20 20 20
Maternal age (years) ‡ 
 < 20 10 (50%) 9 (45%) 0 (0%)
 20–24 8 (40%) 9 (45%) 12 (60%)
 25+ 2 (10%) 2 (10%) 8 (40%)
Maternal attained education
 None 3 (15%) 1 (5%) 5 (25%)
 1–4 years 5 (25%) 6 (30%) 7 (35%)
 5 + years 12 (60%) 13 (65%) 8 (40%)
Household income (Rwandan francs)
 < 1,000 6 (30%) 9 (45%) 7 (35%)
 1,000–4,999 9 (45%) 6 (30%) 10 (50%)
 5,000+ 4 (20%) 4 (20%) 3 (15%)
Number of previous pregnancies
 None 10 (50%) 7 (35%) 6 (30%)
 1–2 7 (35%) 11 (55%) 8 (40%)
 3+ 3 (15%) 2 (10%) 6 (30%)
Baby birth weight § 
 < 2,500 grams 9 (45%) 6 (30%) 2 (10%)
 2,500 + grams 11 (55%) 14 (70%) 18 (90%)
Any sex partner other than father of baby ‡ 
 None 7 (35%) 11 (55%) 19 (95%)
 At least one 12 (60%) 9 (45%) 1 (5%)
History of malaria in the past 3 years
 No malaria 5 (25%) 7 (35%) 7 (35%)
 Malaria but not 
 laboratory confirmed 2 (10%) 4 (20%) 6 (30%)
 Laboratory confirmed malaria 13 (65%) 8 (40%) 7 (35%)
History of sexually transmitted diseases in the past 3 years § 
 None 9 (45%) 11 (55%) 17 (85%)
 1 4 (20%) 2 (10%) 2 (10%)
 2+ 7 (35%) 7 (35%) 1 (5%)
Among HIV-infected women only
Major or minor symptoms of AIDS
 None 11 (55%) 12 (60%)
 1 8 (40%) 6 (30%)
 2+ 1 (5%) 2 (10%)
CD4%
 < 30% 10 (50%) 4 (20%)
 ≥ 30% 10 (50%) 16 (80%)
CD4/CD8 ratio
 < 0.50 6 (30%) 4 (20%)
 ≥ 0.50 10 (50%) 12 (60%)
 *  HIV = human immunodeficiency virus; AIDS = acquired immunodeficiency syndrome. 
 †  Some cells do not total 20 because of missing values. 
 ‡  χ 2 test statistic for overall association  P < 0.005. 
 §  χ 2 test statistic for overall association  P < 0.05. 
 Table 2 
 Number of women, odds ratio (OR), and 95% confidence intervals 
(CI) for mother-to-child transmission of human immunodeficiency 
virus-1 (HIV-1) by maternal and placenta characteristics 
Total Transmitter Non-transmitter OR (95% CI)
Placental malaria
 Yes 22 15 7 5.6 (1.4–21.9)
 No 18 5 13 1.0 (ref)
Placental membrane inflammation
 Yes 9 7 2 4.8 (0.9–27.2)
 No 31 13 18 1.0 (ref)
Placental weight
 < 450 grams 9 6 3 2.4 (0.5–11.5)
 ≥ 450 grams 31 14 17 1.0 (ref)
Birth weight
 < 2,500 grams 14 8 6 1.7 (0.5–6.4)
 ≥ 2,500 grams 25 11 14 1.0 (ref)
Number of sex partners during pregnancy
 1 18 7 11 1.0 (ref)
 ≥ 2 20 11 9 1.9 (0.5–7.0)
Syphilis infection (by VDRL)
 Positive 7 3 4 0.75 (0.1–3.9)
 Negative 32 16 16 1.0 (ref)
Maternal CD4/CD8 ratio
 < 0.5 12 8 4 2.8 (0.7–11.9)
 ≥ 0.5 24 10 14 1.0 (ref)
CD4 percent
 < 30 14 10 4 4.0 (1.0–16.3)
 ≥ 30 26 10 16 1.0 (ref)
Ultrasensitive p24 antigen
 < 1,000 12 6 6 1.0 (ref)
 ≥ 1,000 27 14 13 1.1 (0.3–4.2)
Primigravidae
 Yes 16 9 7 1.7 (0.5–6.1)
 No 23 10 13 1.0 (ref)
Duration of membrane rupture
 < 4 hours 28 13 15 1.0 (ref)
 ≥ 4 hours 10 6 4 1.7 (0.4–7.5)
 Table 3 
 Adjusted odds ratio (aOR) and 95% confidence intervals (CI) for 
mother-to-child transmission of human immunodeficiency virus-1 
(HIV-1) by simultaneous examination of placental malaria, mater-
nal CD4%, and maternal p24 antigen 
aOR (95% CI)
Placental malaria*
 Yes 6.3 (1.4–29.1)
 No 1.0 (ref)
CD4 percent
 < 30 4.8 (1.0–24.0)
 ≥ 30 1.0 (ref)
Ultrasensitive p24 antigen
 < 1,000 1.0 (ref)
 ≥ 1,000 1.1 (0.2–5.2)
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 DISCUSSION 
 In this nested case-control study of rural Rwandan mothers 
followed from 1989 to 1994, we found that PM was indepen-
dently associated with MTCT of HIV-1, particularly among 
primigravidae, before the regional availability of antiretrovi-
ral therapy or prophylaxis. Our results are consistent with a 
recently published study conducted in rural Rakai, Uganda, 14 
but differ from findings reported in Blantyre, Malawi, 11 
Nairobi, 12 Mombasa, 13 and Nyanza Province, Kenya. 15 These 
differences may be explained in part by the varying dynam-
ics of malaria infection and epidemiology in different settings 
and altitudes. The PM may have a greater effect on MTCT 
of HIV-1 in rural as opposed to urban areas, possibly caused 
by higher malaria disease burden among pregnant women or 
reduced access to malaria treatment in rural areas. Differences 
in PM diagnostic techniques may also account for some of the 
observed differences among studies. In this study, PM was 
diagnosed by H&E staining, Giemsa staining, and immuno-
histochemistry, which serve as markers for chronic infection 
and have been shown to be more sensitive than peripheral or 
placental blood films. 26 The histopathological findings of our 
study are characteristic of chronic or acute active malarial 
infection. 23 Our results suggest that PM may partially explain 
the observed seasonal variation in rates of MTCT in some set-
tings. 27 Primigravidae, among whom malaria tends to be most 
severe, may be at higher risk. Our finding that primigravidae 
with observed PM were at higher risk of MTCT of HIV than 
multigravidae may reflect a protective effect of pregnancy-
specific malaria immunity, which has been shown to be absent 
in the first pregnancy. 6 
 The PM may affect MTCT through several possible mecha-
nisms, including up-regulation of CCR5 chemokine co-recep-
tor expression on placental macrophages as a consequence of 
malaria infection. 28 In addition, compromised integrity of the 
placenta caused by inflammation may increase tissue suscepti-
bility to viral infection and promote increased placental virus 
load. 11, 29 We did not observe an association between HIV-1 
MTCT and ultrasensitive p24 antigen level, a proxy for viral 
load, suggesting that local rather than systemic virus replica-
tion may be responsible for vertical transmission. 
 This study has several limitations, including its small sam-
ple size. In agreement with requirements from the Rwandan 
Ministry of Health, most specimens collected from cohort 
women and infants were kept at the National University of 
Rwanda project laboratory and these were all destroyed as a 
result of the civil war in April 1994, severely limiting the num-
ber of additional specimens that could be tested. Another limi-
tation is the lack of data on maternal viral load as a measure 
of HIV disease severity (only ultrasensitive p24 antigen was 
available). The strengths of the study include the nested case-
control design, random selection of control placentas, high 
follow-up rate of the cohort, high rate of placental retrieval 
after delivery, and precise exposure and outcome assessment, 
all of which serve to reduce selection and information bias and 
hence improve the precision of our findings. In addition, this 
analysis focused on data and placenta specimens from treat-
ment-naive pregnant women and infants in rural East Africa, 
yielding results that could not be duplicated in the present-day 
highly active antiretroviral therapy (HAART) era. 
 Although antiretroviral prophylaxis and treatment have 
been shown to reduce rates of MTCT more than 10-fold, 30 
many HIV-infected pregnant women, especially in malaria-
endemic rural areas of sub-Saharan Africa, do not yet have 
access to antiretroviral treatment or prophylaxis. 31 Prevention 
and treatment of malaria among pregnant women through 
established interventions such as insecticide-treated bed nets 
and artemisinin combination anti-malarial treatment, as well 
as control strategies under development to interrupt parasite 
transmission dynamics, may reduce rates of MTCT of HIV-1, 
particularly in hyper-endemic areas with high rates of malaria 
transmission among rural households. 32, 33 Although no studies 
have reported on the association between PM and MTCT of 
HIV-1 in the context of maternal HAART during pregnancy, 
we speculate that the impact of placental malaria on the risk 
of MTCT of HIV-1 in these mothers may be limited, particu-
larly among those with undetectable virus. However, the path-
ological changes caused by PM including focal villitis, cellular 
infiltration of the intervillous space, chorioamnionitis, and vas-
culitis could provide a portal of entry for infected maternal 
cells into the fetal circulation despite suppression of HIV-1 
RNA. Additional studies in malaria-endemic settings among 
HIV-infected mothers may elucidate the relationship among 
HAART, PM, and MTCT of HIV-1 and the biological and 
epidemiological factors that underlie this relationship. In the 
current context of maternal and infant antiretroviral prophy-
laxis and treatment, studies of drug interactions and potential 
toxicities when antiretroviral therapy and antimalarials are 
co-administered in pregnancy are also needed . 
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